WO2007106284A3 - Silicone based emulsions for topical drug delivery - Google Patents

Silicone based emulsions for topical drug delivery Download PDF

Info

Publication number
WO2007106284A3
WO2007106284A3 PCT/US2007/004011 US2007004011W WO2007106284A3 WO 2007106284 A3 WO2007106284 A3 WO 2007106284A3 US 2007004011 W US2007004011 W US 2007004011W WO 2007106284 A3 WO2007106284 A3 WO 2007106284A3
Authority
WO
WIPO (PCT)
Prior art keywords
emulsion
dispersed
dissolved
drug delivery
silicone based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/004011
Other languages
French (fr)
Other versions
WO2007106284A2 (en
Inventor
Gareth Winckle
David W Osborne
Gordon J Dow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Pharmaceutical Sciences Inc
Original Assignee
Dow Pharmaceutical Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Pharmaceutical Sciences Inc filed Critical Dow Pharmaceutical Sciences Inc
Priority to EP07750823A priority Critical patent/EP1996170A2/en
Publication of WO2007106284A2 publication Critical patent/WO2007106284A2/en
Publication of WO2007106284A3 publication Critical patent/WO2007106284A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)

Abstract

A water-in-oil emulsion is provided in which the lipophilic phase of the emulsion contains a silicone fluid and an emulsifier, a hydrophilic phase, and a pharmaceutically active compound. The active pharmaceutical ingredient is dissolved or dispersed in the emulsion and is partitioned in the emulsion so that all or a portion of the amount of the chemical compound dissolved or dispersed in the emulsion is dissolved or dispersed in the aqueous phase of the emulsion. The emulsion of the invention provides increased penetration into skin of the chemical compound dissolved or dispersed in the aqueous phase.
PCT/US2007/004011 2006-03-03 2007-02-15 Silicone based emulsions for topical drug delivery Ceased WO2007106284A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07750823A EP1996170A2 (en) 2006-03-03 2007-02-15 Silicone based emulsions for topical drug delivery

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US77882506P 2006-03-03 2006-03-03
US60/778,825 2006-03-03
US11/699,906 2007-01-30
US11/699,906 US20070207107A1 (en) 2006-03-03 2007-01-30 Silicone based emulsions for topical drug delivery

Publications (2)

Publication Number Publication Date
WO2007106284A2 WO2007106284A2 (en) 2007-09-20
WO2007106284A3 true WO2007106284A3 (en) 2008-06-26

Family

ID=38471683

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/004011 Ceased WO2007106284A2 (en) 2006-03-03 2007-02-15 Silicone based emulsions for topical drug delivery

Country Status (3)

Country Link
US (1) US20070207107A1 (en)
EP (1) EP1996170A2 (en)
WO (1) WO2007106284A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
DE102010006612A1 (en) 2010-02-01 2011-08-04 Beiersdorf AG, 20253 Stabilized preparations based on water in silicone or silicone in water emulsion comprising butylene glycols
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
US20150141389A1 (en) * 2012-04-27 2015-05-21 Dow Corning Corporation Topical Formulation Compositions Containing Silicone Based Excipients To Deliver Actives To A Substrate
US20140335172A1 (en) * 2013-05-10 2014-11-13 The University Of Hong Kong Ophthalmological rinsing agent and methods therefof
MX363386B (en) 2013-10-03 2019-03-20 Dow Pharmaceutical Sciences Stabilized efinaconazole compositions.
KR102612453B1 (en) 2013-11-22 2023-12-08 다우 파마슈티컬 사이언시즈, 인코포레이티드 Anti-infective methods, compositions, and devices
WO2015081007A1 (en) * 2013-11-26 2015-06-04 Humco Holding Group, Inc. Transdermal silicone gel (silogel) compositions and methods of preparation
US9351996B1 (en) * 2015-03-11 2016-05-31 Sayed Antar Topical cream composition
WO2017188957A1 (en) * 2016-04-28 2017-11-02 Antar Sayed Topical cream composition
US20210161870A1 (en) 2017-06-07 2021-06-03 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
US11129818B2 (en) 2017-06-07 2021-09-28 Arcutis Biotherapeutics, Inc. Topical roflumilast formulation having improved delivery and plasma half life
US12011437B1 (en) 2017-06-07 2024-06-18 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
US12042487B2 (en) 2018-11-16 2024-07-23 Arcutis Biotherapeutics, Inc. Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
US9895359B1 (en) 2017-06-07 2018-02-20 Arcutis, Inc. Inhibition of crystal growth of roflumilast
US20200155524A1 (en) 2018-11-16 2020-05-21 Arcutis, Inc. Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
CA3102689C (en) 2018-06-04 2023-08-29 Arcutis, Inc. Method and formulation for improving roflumilast skin penetration lag time
US11337995B2 (en) * 2018-11-06 2022-05-24 Epsom-It, Inc. Peripheral neuropathy composition and related methods
CN116963717A (en) 2020-12-04 2023-10-27 阿尔库缇斯生物疗法股份有限公司 Topical roflumilast formulation with antifungal properties
IL313866A (en) 2021-12-28 2024-08-01 Arcutis Biotherapeutics Inc Topical roflumilast aerosol foams
IL319352A (en) 2022-09-15 2025-05-01 Arcutis Biotherapeutics Inc Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009609A1 (en) * 1993-10-07 1995-04-13 Astra Aktiebolag New emulsion formulation
US6080394A (en) * 1999-11-08 2000-06-27 Dow Corning Corporation Polar solvent-in-oil emulsions and multiple emulsions
US20020022010A1 (en) * 2000-05-08 2002-02-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic compositions
US20020136743A1 (en) * 1996-05-17 2002-09-26 Anne Langlois Cosmetic compositions
US6537537B2 (en) * 1997-06-12 2003-03-25 The Procter & Gamble Company Water-in-silicone emulsion cosmetic compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2005109A (en) * 1930-11-26 1935-06-18 Hussmann Ligonier Company Slicing machine
GB8914905D0 (en) * 1989-06-29 1989-08-23 Unilever Plc Cosmetic composition
US5599533A (en) * 1994-12-15 1997-02-04 Estee Lauder, Inc. Stable water-in-oil emulsion system
ZA966814B (en) * 1995-08-18 1998-02-12 Colgate Palmolive Co Clear cosmetic gel composition.
US5939082A (en) * 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
HU228855B1 (en) * 1997-03-12 2013-06-28 Abbott Lab Hydrophilic binary systems for the administration of cyclosporine
AU753270B2 (en) * 1998-05-21 2002-10-10 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
US6071975A (en) * 1999-01-11 2000-06-06 Dow Corning Corporation Method of preparing silicone oil-in-water microemulsions
US6685952B1 (en) * 1999-06-25 2004-02-03 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions and methods-high internal phase water-in-volatile silicone oil systems
GB0106507D0 (en) * 2001-03-16 2001-05-02 Entomos Sciences Ltd Arthropodicidal compositions
US6485716B1 (en) * 2001-10-05 2002-11-26 Colgate-Palmolive Company High efficacy liquid gel product
US6861061B2 (en) * 2001-12-19 2005-03-01 Dow Corning Corporation Stabilization of vitamins in water-in silicone oil (W/O) emulsions
US20040166083A1 (en) * 2003-02-26 2004-08-26 The Andrew Jergens Company Personal care water-in-oil emulsion products

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009609A1 (en) * 1993-10-07 1995-04-13 Astra Aktiebolag New emulsion formulation
US20020136743A1 (en) * 1996-05-17 2002-09-26 Anne Langlois Cosmetic compositions
US6537537B2 (en) * 1997-06-12 2003-03-25 The Procter & Gamble Company Water-in-silicone emulsion cosmetic compositions
US6080394A (en) * 1999-11-08 2000-06-27 Dow Corning Corporation Polar solvent-in-oil emulsions and multiple emulsions
US20020022010A1 (en) * 2000-05-08 2002-02-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHIDAMBARAM ET AL.: "Mathematical Modeling of Surface-Active and Non-Surface-Active Drug Transport in Emulsion Systems", AAPS PHARMASCI., vol. 2, no. 3, September 2000 (2000-09-01), pages 1 - 12, XP008130325 *

Also Published As

Publication number Publication date
US20070207107A1 (en) 2007-09-06
EP1996170A2 (en) 2008-12-03
WO2007106284A2 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
WO2007117352A3 (en) Topical therapeutic delivery system
TW200613004A (en) External preparation of solid/oil type
AU2001287918A1 (en) Preparation of vitamin emulsions and concentrates thereof
Rajpoot et al. Microemulsion as drug and gene delivery vehicle: an inside story
CO6361898A2 (en) MODIFIED RELEASE EMULSIONS FOR APPLICATION IN THE SKIN OR IN THE VAGINAL MUCOSA
ATE415942T1 (en) OPHTHALMIC EMULSIONS CONTAINING PROSTAGLANDINS
WO2006015299A3 (en) Multi-reservoir device for transdermal drug delivery and sensing
BRPI0415858A (en) compounds of tocopherol-modified therapeutic drugs
NZ603686A (en) Topical formulation for a jak inhibitor
WO2007133768A3 (en) Method of enhancing penetration of water-soluble actives
BRPI0819115A2 (en) Liquid aqueous formulation, nasal drug dispensing device or dosage cartridge, and use of solubilizing agent.
WO2010074540A2 (en) Pharmaceutical composition containing an anionic drug, and a production method therefor
WO2002094172A3 (en) Compartmentalized dosage form
WO2008157103A3 (en) Modified release solid or semi-solid dosage forms
EP4670721A3 (en) Microemulsion for opthalmic drug delivery
EP2258441A3 (en) Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs
BRPI0910341A8 (en) device for the conservation, spontaneous preparation and administration of an active ingredient
WO2004089336A3 (en) Drug delivery systems comprising an encapsulated active ingredient
BRPI0411306A (en) pharmaceutical compositions comprising vitamin D active compounds
ATE555777T1 (en) PHARMACEUTICAL COMPOSITION
WO2005055836A3 (en) Active suture for the delivery of therapeutic fluids
WO2002089778A3 (en) Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
EE200200483A (en) New self-emulsifying drug delivery system
ATE322250T1 (en) SELF-EMULSIFYING SYSTEM FOR DRUG DELIVERY OF FAT-SOLUBLE ACTIVE INGREDIENTS
WO2011115489A3 (en) Spray-pumpable composition suitable for topical skin application

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07750823

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007750823

Country of ref document: EP